Ascendis Pharma A/S (ASND) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Ascendis Pharma A/S

    NASDAQ: ASND · Real-Time Price · USD
    204.15
    -1.76 (-0.85%)
    At close: Sep 08, 2025, 12:25 PM

    Ascendis Pharma A/S Balance Sheet Statement

    Financials in EUR. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Cash & Equivalents
    		 559.54M 392.16M 444.77M 446.27M
    Short-Term Investments
    		 n/a 7.28M 290.69M 235.8M
    Long-Term Investments
    		 13.57M 5.69M 30.42M 145.91M
    Other Long-Term Assets
    		 2.32M 2.13M 1.92M 1.81M
    Receivables
    		 166.28M 35.87M 11.91M 2.2M
    Inventory
    		 295.61M 208.93M 130.67M 75.41M
    Other Current Assets
    		 11.16M 19.9M 13.72M 20.99M
    Total Current Assets
    		 1.06B 702.72M 923.47M 805.89M
    Property-Plant & Equipment
    		 98.71M 110.63M 129.09M 126.05M
    Goodwill & Intangibles
    		 4.03M 4.42M 4.83M 5.27M
    Total Long-Term Assets
    		 118.63M 122.87M 166.27M 279.04M
    Total Assets
    		 1.18B 825.59M 1.09B 1.08B
    Account Payables
    		 96.39M 94.57M 101.03M 59.42M
    Deferred Revenue
    		 936K n/a n/a 2.6M
    Short-Term Debt
    		 491.54M 407.1M 412.98M 7M
    Other Current Liabilities
    		 317.77M 179.5M 183.49M 24.15M
    Total Current Liabilities
    		 907.86M 736.51M 716.78M 100.36M
    Long-Term Debt
    		 365.08M 138.38M 95.4M 97.97M
    Other Long-Term Liabilities
    		 n/a 11.78M -95.4M -97.97M
    Total Long-Term Liabilities
    		 377.34M 234.78M 109.61M 100.93M
    Total Liabilities
    		 1.29B 971.28M 826.39M 201.29M
    Total Debt
    		 856.62M 644.26M 617.57M 209.92M
    Common Stock
    		 8.15M 7.75M 7.67M 7.65M
    Retained Earnings
    		 -2.56B -2.28B -1.86B -1.24B
    Comprehensive Income
    		 1.78M 721K 3.45M 3.78M
    Shareholders Equity
    		 -105.71M -145.7M 263.35M 883.63M
    Total Investments
    		 13.57M 12.96M 321.11M 381.7M

    Add to Watchlist